CACI Acquires IDL Solutions, Inc.
Acquisition Positions Company for Strategic Growth in Healthcare
IT Market
CACI International Inc (NYSE:
CACI) announced today that it has acquired IDL Solutions, Inc., a
leading provider of information technology solutions, applications, and
mission-critical systems support to healthcare IT clients and other
civilian agencies. This acquisition expands CACI’s presence in the $33.5
billion addressable healthcare market and the federal health insurance
area in particular, and complements its November 2012 acquisition of
healthcare IT provider Emergint Technologies, Inc.
Founded in 1993, IDL Solutions has over 100 employees and is
headquartered in Germantown, Wisconsin with federal offices in Reston,
Virginia. The company leverages “big data” analytics to help healthcare
organizations gain new insights from large volumes of health data, which
in turn drives cost-effective business processes, improves patient care,
and increases mission success. Its workforce has extensive experience in
application development, data analytics, and business automation and IT
support. The company has achieved the Software Engineering Institute’s
globally recognized, independent assessment of CMMI® Level 3.
IDL Solutions has major contract vehicles at the Department of Health
and Human Services (HHS), specifically with the Centers for Medicare and
Medicaid Services, Food and Drug Administration, and National Institutes
of Health. Its 2012 revenue is expected to be approximately $18.5
million, and the acquisition is expected to be slightly accretive to
CACI’s earnings per share during its first 12 months. Terms of the
transaction were not disclosed.
John Mengucci, CACI Chief Operating Officer and President of U.S.
Operations, said, “With our acquisition of IDL Solutions, CACI has
specialized capabilities to address the challenges of clients in the
federal civilian healthcare and health insurance spaces. In particular,
IDL Solutions’ expertise in big data will enable us to provide the
critical data collection, storage, analysis, and dissemination
capabilities that enable healthcare organizations to improve customer
service, minimize fraudulent activities, and promote better patient
care.”
According to Dan Allen, CACI President and Chief Executive Officer,
“CACI’s acquisition of IDL Solutions, coupled with our recent
acquisition of Emergint Technologies, is an important step in our
strategy to build CACI’s healthcare IT business. This acquisition falls
under our newly formed Federal Civilian Solutions business group, which
includes healthcare, and aligns with our ongoing growth strategy to gain
a larger share of the rapidly growing Healthcare IT market.”
IDL Solutions, Inc. President and Chief Executive Officer Baly
Ambegaoker said, “We look forward to bringing our committed team and
healthcare analytics capabilities to CACI and growing together as we
continue to address mission challenges across the federal healthcare IT
landscape.”
CACI provides information solutions and services in support of national
security missions and government transformation for Intelligence,
Defense, and Federal Civilian clients. A member of the Fortune 1000
Largest Companies and the Russell 2000 Index, CACI provides dynamic
careers for approximately 14,900 employees working in over 120 offices
worldwide. Visit www.caci.com.
There are statements made herein which do not address historical
facts, and therefore could be interpreted to be forward-looking
statements as that term is defined in the Private Securities Litigation
Reform Act of 1995. Such statements are subject to factors that could
cause actual results to differ materially from anticipated results. The
factors that could cause actual results to differ materially from those
anticipated include, but are not limited to, the successful closing and
integration of our acquisition of IDL Solutions, actual revenue and
earnings realized by IDL Solutions and the performance of the financial
management and business services business as well as the risk factors
set forth in CACI’s Annual Report on Form 10-K for the fiscal year ended
June 30, 2012, and other such filings that CACI makes with the
Securities and Exchange Commission from time to time. Any
forward-looking statements should not be unduly relied upon and only
speak as of the date hereof.
CMMI is registered in the U.S. Patent and Trademark Office by Carnegie
Mellon University
CACI-Acquisition